The medical industry briefing
The latest news, approvals and clinical trials you need to know about this month
News in Numbers
1 in 100
A large, international study found that around 1 in every 100 patients hospitalised with Covid-19 have brain complications.
$7.8bn
Medtronic has announced revenue of $7.8bn for Q2 FY22, missing forecasts due to labour shortages and a resurgence of Covid-19 cases.
£250m
The NHS will receive nearly £250m to digitise diagnostics care across the NHS using new technology.
33%
After ramping up production to meet demand during the Covid-19 pandemic, Indian medical device makers are now struggling with idle capacity of around 33%.
$61m
Medical AI provider Lunit has raised $61m in a pre-IPO fundraising round ahead of its South Korean stock market public offering early next year.
Top Stories
UK to investigate potential bias in medical devices
The UK Government’s Department of Health and Social Care has launched a review of the health impact of potential bias in medical devices. The independent review will look at potential bias in technologies such as oxygen measuring devices and the impact on patients from different ethnic groups. Initial findings expected in late January 2022.
Source: gov.uk
US invests $1.5bn in healthcare
The US Government has announced an investment of $1.5bn under the American Rescue Plan to address healthcare staff shortages and improve workforce equity. The funding for the National Health Service Corps and Nurse Corps aims to expand diversity in the healthcare sector and improve critical clinical care in underserved communities.
Source: White House
Gender bias in Australian research funding
Women secure a smaller share of medical research funding than men from the Australian National Health and Medical Research Council despite applying at a similar rate, analysis has found. The gender bias in Australia’s largest grant-award programme was first flagged in 2019 but now thousands of people have signed a petition calling for gender quotas.
Source: Nature
From shark skin to new medical devices
The antimicrobial properties of shark skin could inspire the development of materials that prevent the spread of bacteria and biofouling, according to a new study by Chinese scientists published in Science Direct. Scientists studied the surface characteristics of shark skin and how they could be simulated to achieve similar antimicrobial properties for medical device coatings.
Source: News Medical
Embracing Emerging Technologies
Brain-computer interface for mobility
Blackrock Neurotech's MoveAgain brain-computer interface has received breakthrough device designation from the FDA. The first-of-its-kind system aims to provide immobile patients the ability to control a mouse cursor, keyboard, mobile device or tablet, wheelchair or prosthetic device simply by thinking.
Source: Blackrock Neurotech
Exo-suit for stroke survivors
The FDA has awarded breakthrough device designation to ReWalk’s ReBoot soft exo-suit. The lightweight, battery-powered orthotic exoskeleton is intended to assist people with reduced ankle function related to neurological injuries, such as stroke, with walking and mobility.
Source: ReWalk Robotics
New treatment for cognitive impairment
Another recent recipient of FDA breakthrough device designation is Renew Bioscience’s Cerezen device to treat Alzheimer’s Disease-related mild cognitive impairment and mild dementia. The non-invasive, drug-free treatment is designed to improve cerebral vascular health by enhancing circulation, simulating the physiological effects of vigorous exercise.
Source: Renew Bioscience
Nines
US-based company Nines is a tele-radiology and artificial intelligence startup. Its product NinesAI is FDA-cleared to triage time-critical, life-threatening indications of mass effect and intracranial hemorrhage.
Source: Nines
Lucira Health
Biotechnology company Lucira Health offers disposable at-home test kits to detect infectious diseases, such as Covid-19.
Source: Lucira Health
Bloomlife
US-based company Bloomlife is using technology, data science and medical expertise to address issues in maternal health.
Source: Bloomlife